登录 | 注册    关注公众号  
微信公众号
搜索
 >  Protein>IL-5 >IL5-H52H3

Human IL-5 Protein, His Tag, premium grade

分子别名(Synonym)

IL-5,TRF,IL5,Interleukin-5

表达区间及表达系统(Source)

Human IL-5, His Tag, premium grade (IL5-H52H3) is expressed from human 293 cells (HEK293). It contains AA Ile 20 - Ser 134 (Accession # P05113-1).

Predicted N-terminus: His

Human IL-5, His Tag, premium grade (IL5-H52H3), designed for preclinical stage, has the same activity and performance with GMP Human IL-5, which enables a seamless transition from preclinical development to clinical phases. Premium Grade product offer a cost efficient alternative of GMP Grade products for the early development phase when safety of raw materials is not top priority. By using Premium Grade products in early development phase, you can transition easily into clinical and commercial phase without need to revalidate the raw materials and modify manufacturing process.

Request for sequence

蛋白结构(Molecular Characterization)

IL-5 Structure

This protein carries a polyhistidine tag at the N-terminus

The protein has a calculated MW of 15.0 kDa. The protein migrates as 18-23 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

内毒素(Endotoxin)

Less than 0.1 EU per μg by the LAL method.

无菌(Sterility)

The sterility testing was performed by membrane filtration method.

支原体(Mycoplasma)

Negative.

纯度(Purity)

>90% as determined by SDS-PAGE.

制剂(Formulation)

Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

重构方法(Reconstitution)

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

存储(Storage)

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:

  1. -20°C to -70°C for 12 months in lyophilized state;
  2. -70°C for 3 months under sterile conditions after reconstitution.
 

电泳(SDS-PAGE)

IL-5 SDS-PAGE

Human IL-5, His Tag, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

 

活性(Bioactivity)-Bioactivity CELL BASE

IL-5 CELL

Human IL-5, His Tag, premium grade (Cat. No. IL5-H52H3) stimulates proliferation of 293F-STAT5/Luc-IL5RA-CD131-9 cells. The typically EC50 for this effect is 3.909 ng/mL (QC tested).

Protocol

 

活性(Bioactivity)-ELISA

IL-5 ELISA

Immobilized Human IL-5 Protein, His Tag, premium grade (Cat. No. IL5-H52H3) at 5 μg/mL (100 μL/well) can bind Human IL-5 R alpha, Fc Tag with a linear range of 0.02-0.313 μg/mL (QC tested).

Protocol

 

活性(Bioactivity)-BLI

IL-5 BLI

Loaded Human IL-5, His Tag, premium grade (Cat. No. IL5-H52H3) on NTA Biosensor, can bind Human IL-5 R alpha, Fc Tag with an affinity constant of 4.63 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol

 

背景(Background)

Interleukin 5 (IL5) is an interleukin produced by type-2 T helper cells and mast cells. IL-5 is a 115-amino acid (in human, 133 in the mouse) -long TH2 cytokine that is part of the hematopoietic family. Unlike other members of this cytokine family (namely interleukin 3 and GM-CSF), this glycoprotein in its active form is a homodimer. Interleukin-5 has long been associated with the cause of several allergic diseases including allergic rhinitis and asthma, wherein a large increase in the number of circulating, airway tissue, and induced sputum eosinophils have been observed. Given the high concordance of eosinophils and, in particular, allergic asthma pathology, it has been widely speculated that eosinophils have an important role in the pathology of this disease. Drugs that target IL-5 are mepolizumab and reslizumab.

 

前沿进展

 
 
货号/价格
产品推荐
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
IL-5靶点信息
英文全称:Interleukin-5
中文全称:白细胞介素-5
种类:Homo sapiens
上市药物数量:2详情
临床药物数量:8详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细
相关产品
View All IL-5

消息提示

请输入您的联系方式,再点击提交!

确定